Viewing Study NCT00619112


Ignite Creation Date: 2025-12-26 @ 11:08 AM
Ignite Modification Date: 2026-02-25 @ 7:04 PM
Study NCT ID: NCT00619112
Status: COMPLETED
Last Update Posted: 2018-01-31
First Post: 2008-02-19
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Temozolomide in Treating Patients With Recurrent High-Grade Glioma
Sponsor: University of California, San Francisco
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent Central Nervous System Neoplasm View
Keywords:

Keywords

Keyword Brief Keyword Text View
None adult glioblastoma View
None adult gliosarcoma View
None adult anaplastic astrocytoma View
None adult anaplastic oligodendroglioma View
None adult mixed glioma View
None recurrent adult brain tumor View